logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
SLN
Silence Therapeutics plc
11.00
1 x 9.75
1 x 13.02
bid
ask
+
0.15
1.38%
09:02 AM
timesize
Ytd80.92%
1y76.00%
10.62
day range
11.08
4.30
52 week range
11.00
Open10.83Prev Close10.85Low10.62High11.08Mkt Cap512.49M
Vol742.00Avg Vol388.92KEPS-1.56P/E-6.96Forward P/EN/A
Beta1.38Short Ratio2.36Inst. Own62.77%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg7.99200-d Avg6.601yr Est53.70

SLN News

SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know
zacks.com
SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know

Silence Therapeutics shares surge as investors eye key 2026 divesiran data, an advancing RNAi pipeli

Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last?
zacks.com
Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last?

Silence Therapeutics (SLN) was a big mover last session on higher-than-average trading volume. The l

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)
seekingalpha.com
Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)

I initiate Silence Therapeutics at a speculative Buy, driven by near-term divesiran/SLN124 catalysts

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?
zacks.com
Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher

This $300 Million Biotech May Be Deeply Mispriced: Analyst
benzinga.com
This $300 Million Biotech May Be Deeply Mispriced: Analyst

Silence Therapeutics Plc (NASDAQ:SLN) stock rose Wednesday after Cantor Fitzgerald initiated coverag

This $300 Million Biotech May Be Deeply Mispriced: Analyst
benzinga.com
This $300 Million Biotech May Be Deeply Mispriced: Analyst

Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major

benzinga.com
Cantor Fitzgerald Initiates Coverage On Silence Therapeutics with Overweight Rating

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN)

Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sess

U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls afte

Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data
benzinga.com
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data

Silence Therapeutics Plc (NASDAQ:SLN) shares are up during Friday's session. On Thursday, the compan

Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data
benzinga.com
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data

Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh d

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
gurufocus.com
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potent

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing nov

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
businesswire.com
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potent

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
businesswire.com
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
businesswire.com
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
businesswire.com
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financia

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” o

Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?
zacks.com
Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” by Brokerages
defenseworld.net
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” b

Shares of Silence Therapeutics PLC Sponsored ADR (NASDAQ: SLN - Get Free Report) have received an av

Why Urgent.ly Shares Are Trading Higher By Around 159%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Urgent.ly Shares Are Trading Higher By Around 159%; Here Are 20 Stocks Moving Premarket

Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per

Silence Therapeutics (NASDAQ:SLN) versus Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Comparison
defenseworld.net
Silence Therapeutics (NASDAQ:SLN) versus Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Comparison

Avalo Therapeutics (NASDAQ: AVTX - Get Free Report) and Silence Therapeutics (NASDAQ: SLN - Get Free

Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High?
zacks.com
Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move T

The consensus price target hints at a 467.5% upside potential for Silence Therapeutics (SLN). While

Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Yea

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN, a global cl

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Recommendation of “Hold” from Brokerages
defenseworld.net
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Recommendation of “Hold” from

Silence Therapeutics PLC Sponsored ADR (NASDAQ: SLN - Get Free Report) has earned a consensus recomm

Silence Therapeutics Announces Leadership Changes
businesswire.com
Silence Therapeutics Announces Leadership Changes

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” o

Silence Therapeutics: Divesiran Targets High-Burden PV
seekingalpha.com
Silence Therapeutics: Divesiran Targets High-Burden PV

Silence Therapeutics is advancing its lead RNAi drug, divesiran, for polycythemia vera, with a fully

Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
businesswire.com
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, Nasdaq: SLN (“Silence” o
benzinga.com
Earnings Scheduled For February 27, 2025
benzinga.com
Earnings Scheduled For March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it